Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyMolecularFunctionaspartic-type endopeptidase activity

ERVK-6 ERVK-7 ERVK-9 ERVK-10 ERVK-19 ERVK-24 ERVK-8 CTSD

4.68e-09372158GO:0004190
GeneOntologyMolecularFunctionaspartic-type peptidase activity

ERVK-6 ERVK-7 ERVK-9 ERVK-10 ERVK-19 ERVK-24 ERVK-8 CTSD

5.88e-09382158GO:0070001
GeneOntologyMolecularFunctionRNA-DNA hybrid ribonuclease activity

ERVK-6 ERVK-7 ERVK-10 ERVK-8

4.07e-06112154GO:0004523
GeneOntologyMolecularFunctionRNA-directed DNA polymerase activity

ERVK-6 ERVK-7 ERVK-10 ERVK-8

1.20e-05142154GO:0003964
GeneOntologyMolecularFunctionRNA endonuclease activity

ERVK-6 ERVK-7 ERVK-10 PIWIL4 DICER1 ERVK-8 SLFN11

2.29e-05792157GO:0004521
GeneOntologyMolecularFunctiondisaccharide binding

LGALS9C LGALS9B LGALS9

4.17e-0572153GO:0048030
GeneOntologyMolecularFunctionRNA endonuclease activity, producing 5'-phosphomonoesters

ERVK-6 ERVK-7 ERVK-10 DICER1 ERVK-8

4.55e-05372155GO:0016891
GeneOntologyMolecularFunctionDNA polymerase activity

ERVK-6 ERVK-7 ERVK-10 POLE2 ERVK-8

5.19e-05382155GO:0034061
GeneOntologyMolecularFunctionRNA stem-loop binding

ERVK-6 ERVK-7 ERVK-10 ERVK-8

6.77e-05212154GO:0035613
GeneOntologyMolecularFunctionpeptidase activity

ERVK-6 USP11 ERVK-7 ERVK-9 ERVK-10 USP9Y ERVK-19 ERVK-24 TMPRSS7 USP43 CPM ADAM32 USP10 AOPEP ERVK-8 PAPPA USP54 CTSD TMPRSS11A

8.97e-0565421519GO:0008233
GeneOntologyMolecularFunctiongalactoside binding

LGALS9C LGALS9B LGALS9

9.86e-0592153GO:0016936
GeneOntologyMolecularFunctionendonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters

ERVK-6 ERVK-7 ERVK-10 DICER1 ERVK-8

1.32e-04462155GO:0016893
GeneOntologyMolecularFunctiontransferase activity, transferring phosphorus-containing groups

EPHB3 ERVK-6 PLK2 HK2 HIPK1 ERVK-7 CHEK1 ERVK-10 TRRAP MLKL PTK2B BUB1B MERTK POLE2 TEX14 GK5 GSK3B NMNAT3 IGF2R CSF1R GYS1 HASPIN ERVK-8

2.07e-0493821523GO:0016772
GeneOntologyMolecularFunctionendopeptidase activity

ERVK-6 USP11 ERVK-7 ERVK-9 ERVK-10 ERVK-19 ERVK-24 TMPRSS7 ADAM32 USP10 ERVK-8 PAPPA CTSD TMPRSS11A

2.48e-0443021514GO:0004175
GeneOntologyMolecularFunctionaxon guidance receptor activity

EPHB3 HMCN2 ROBO1

3.25e-04132153GO:0008046
GeneOntologyMolecularFunctionRNA nuclease activity

ERVK-6 ERVK-7 ERVK-10 PIWIL4 DICER1 ERVK-8 SLFN11

6.87e-041362157GO:0004540
GeneOntologyMolecularFunctionendonuclease activity

ERVK-6 ERVK-7 ERVK-10 PIWIL4 DICER1 ERVK-8 SLFN11

6.87e-041362157GO:0004519
GeneOntologyMolecularFunctionextracellular matrix binding

ITGA2 THSD1 ZAN NTN4 LRRC15

1.15e-03732155GO:0050840
GeneOntologyMolecularFunctionoligosaccharide binding

LGALS9C LGALS9B LGALS9

1.23e-03202153GO:0070492
GeneOntologyBiologicalProcessDNA integration

ERVK-6 ERVK-7 ERVK-10 THAP9 ERVK-8

1.55e-07132195GO:0015074
GeneOntologyBiologicalProcessviral process

ERVK-6 RCC1 ERVK-7 ITGA2 ERVK-9 ERVK-10 ERVK-19 SLC52A2 ERVK-24 GPR15 CH25H DICER1 GSK3B LGALS9 IGF2R CSF1R ERVK-8 LRRC15 TMPRSS11A

5.86e-0746421919GO:0016032
GeneOntologyBiologicalProcessDNA synthesis involved in DNA repair

ERVK-6 ERVK-7 ERVK-10 POLE2 USP43 USP10 ERVK-8

7.03e-07482197GO:0000731
GeneOntologyBiologicalProcessDNA biosynthetic process

ERVK-6 ERVK-7 CHEK1 ERVK-10 PTK2B POLE2 USP43 GSK3B USP10 ARRB2 EGF ERVK-8

3.94e-0621821912GO:0071897
GeneOntologyBiologicalProcessnegative regulation of natural killer cell degranulation

LGALS9C LGALS9B LGALS9

4.69e-0642193GO:0043322
GeneOntologyBiologicalProcesshomophilic cell adhesion via plasma membrane adhesion molecules

DCHS2 CLSTN3 PECAM1 CDH23 CD84 HMCN2 PCDHA7 PCDHA3 HMCN1 ROBO1 CDHR4

5.33e-0618721911GO:0007156
GeneOntologyBiologicalProcesscell-cell adhesion via plasma-membrane adhesion molecules

LGALS9C DCHS2 CLSTN3 LGALS9B PECAM1 CDH23 CD84 HMCN2 PCDHA7 PCDHA3 LGALS9 HMCN1 ROBO1 CDHR4

6.93e-0631321914GO:0098742
GeneOntologyBiologicalProcessregulation of mitotic nuclear division

DLGAP5 RCC1 CHEK1 BUB1B DRD3 TEX14 EGF HASPIN BUB3

1.35e-051342199GO:0007088
GeneOntologyBiologicalProcessnegative regulation of leukocyte degranulation

LGALS9C LGALS9B CD84 LGALS9

2.64e-05172194GO:0043301
GeneOntologyBiologicalProcessnatural killer cell differentiation

LGALS9C LGALS9B MERTK HECTD1 LGALS9

4.86e-05382195GO:0001779
GeneOntologyBiologicalProcessregulation of natural killer cell degranulation

LGALS9C LGALS9B LGALS9

6.36e-0582193GO:0043321
GeneOntologyBiologicalProcessregulation of nuclear division

DLGAP5 RCC1 CHEK1 BUB1B DRD3 TEX14 EGF HASPIN BUB3

9.58e-051722199GO:0051783
GeneOntologyBiologicalProcesscell-substrate adhesion

EPHB3 NEXMIF PECAM1 ITGA2 THSD1 SVEP1 PTK2B MERTK FERMT1 LAMA5 DICER1 GSK3B NTN4 MSLN

1.32e-0441021914GO:0031589
GeneOntologyBiologicalProcessmitotic nuclear division

DLGAP5 KIF4A RCC1 CHEK1 BUB1B KLHDC8B DRD3 TEX14 EGF HASPIN KIF4B BUB3

1.51e-0431621912GO:0140014
GeneOntologyBiologicalProcessregulation of regulatory T cell differentiation

LGALS9C LGALS9B FANCA DICER1 LGALS9

1.68e-04492195GO:0045589
GeneOntologyCellularComponentextracellular matrix

THSD4 LGALS9C IMPG1 LGALS9B LRRTM3 ZP2 SVEP1 FCGBP HMCN2 ZAN LAMA5 LGALS9 NTN4 HMCN1 LRIG1 LGR6 CTSD RTN4RL2 FBN3 LRRC15

2.33e-0565622120GO:0031012
GeneOntologyCellularComponentexternal encapsulating structure

THSD4 LGALS9C IMPG1 LGALS9B LRRTM3 ZP2 SVEP1 FCGBP HMCN2 ZAN LAMA5 LGALS9 NTN4 HMCN1 LRIG1 LGR6 CTSD RTN4RL2 FBN3 LRRC15

2.43e-0565822120GO:0030312
GeneOntologyCellularComponentdimeric IgA immunoglobulin complex

IGHA1 IGHA2

3.31e-0432212GO:0071750
GeneOntologyCellularComponentsecretory dimeric IgA immunoglobulin complex

IGHA1 IGHA2

3.31e-0432212GO:0071752
DomainEGF-like_dom

CNTNAP3B IMPG1 CNTNAP3 PTGS2 SVEP1 FCGBP HMCN2 ZAN LAMA5 ADAM32 MALRD1 EGF HMCN1 FBN3

1.08e-0624921314IPR000742
DomainEGF_1

CNTNAP3B CNTNAP3 PTGS2 SVEP1 HMCN2 ZAN LAMA5 ADAM32 NTN4 MALRD1 EGF HMCN1 FBN3

7.71e-0625521313PS00022
DomainConA-like_dom

LGALS9C CNTNAP3B CLSTN3 LGALS9B CNTNAP3 SVEP1 RYR3 ZAN LAMA5 LGALS9 MALRD1 PAPPA

8.40e-0621921312IPR013320
Domain-

LGALS9C CLSTN3 LGALS9B CNTNAP3 SVEP1 LAMA5 LGALS9 PAPPA

1.30e-059521382.60.120.200
DomainEGF

CNTNAP3B CNTNAP3 PTGS2 SVEP1 FCGBP ZAN LAMA5 ADAM32 MALRD1 EGF HMCN1 FBN3

1.71e-0523521312SM00181
Domain-

ERLEC1 IGF2R PRKCSH

2.85e-05621332.70.130.10
DomainEGF-like_CS

CNTNAP3 PTGS2 SVEP1 HMCN2 ZAN LAMA5 ADAM32 NTN4 MALRD1 EGF HMCN1 FBN3

4.78e-0526121312IPR013032
DomainEGF_2

CNTNAP3B CNTNAP3 PTGS2 SVEP1 HMCN2 ZAN LAMA5 ADAM32 MALRD1 EGF HMCN1 FBN3

5.53e-0526521312PS01186
DomainMan6P_isomerase_rcpt-bd_dom

ERLEC1 IGF2R PRKCSH

7.85e-0582133IPR009011
DomainEGF_3

CNTNAP3B CNTNAP3 PTGS2 SVEP1 HMCN2 ZAN ADAM32 MALRD1 EGF HMCN1 FBN3

8.43e-0523521311PS50026
DomainEGF

CNTNAP3 PTGS2 SVEP1 ZAN MALRD1 EGF HMCN1 FBN3

9.96e-051262138PF00008
DomainGalactose-bd-like

EPHB3 CNTNAP3B CNTNAP3 FBXO17 HECTD1 LAMA5 NTN4

1.00e-04942137IPR008979
DomainGFP-like

SVEP1 EGF HMCN1

2.26e-04112133IPR023413
DomainEphrin_rec_like

EPHB3 SVEP1 TG

2.26e-04112133PF07699
Domain-

SVEP1 EGF HMCN1

2.26e-041121332.40.155.10
DomainDUF4599

SPATA31A7 SPATA31A3 SPATA31A5

2.98e-04122133PF15371
DomainDUF4599

SPATA31A7 SPATA31A3 SPATA31A5

2.98e-04122133IPR027970
DomainTILa_dom

FCGBP ZAN

3.85e-0432132IPR025615
DomainTILa

FCGBP ZAN

3.85e-0432132PF12714
DomainGrowth_fac_rcpt_

EPHB3 SVEP1 HMCN2 LAMA5 NTN4 EGF HMCN1 FBN3

4.30e-041562138IPR009030
DomainCUB_dom

CSMD3 MGAT3 TMPRSS7 CRHBP SEZ6L

4.76e-04572135IPR000859
DomainGalectin_CRD

LGALS9C LGALS9B LGALS9

6.01e-04152133IPR001079
Domain-

IMPG1 TMPRSS7 TMPRSS11A

6.01e-041521333.30.70.960
DomainGal-bind_lectin

LGALS9C LGALS9B LGALS9

6.01e-04152133PF00337
DomainGal-bind_lectin

LGALS9C LGALS9B LGALS9

6.01e-04152133SM00908
DomainGALECTIN

LGALS9C LGALS9B LGALS9

6.01e-04152133PS51304
DomainGLECT

LGALS9C LGALS9B LGALS9

6.01e-04152133SM00276
DomainPkinase_Tyr

EPHB3 MLKL PTK2B MERTK TEX14 CSF1R HASPIN

7.02e-041292137PF07714
DomainG2F

HMCN2 HMCN1

7.65e-0442132PF07474
DomainNIDOGEN_G2

HMCN2 HMCN1

7.65e-0442132PS50993
DomainGFP

HMCN2 HMCN1

7.65e-0442132IPR009017
DomainPRKCSH

ERLEC1 PRKCSH

7.65e-0442132IPR012913
DomainPRKCSH

ERLEC1 PRKCSH

7.65e-0442132PF07915
DomainG2_nidogen/fibulin_G2F

HMCN2 HMCN1

7.65e-0442132IPR006605
DomainLRR_TYP

LRRC66 LRRC49 LRRTM3 TPBGL LRIG1 LGR6 RTN4RL2 LRRC15

9.85e-041772138SM00369
DomainLeu-rich_rpt_typical-subtyp

LRRC66 LRRC49 LRRTM3 TPBGL LRIG1 LGR6 RTN4RL2 LRRC15

9.85e-041772138IPR003591
DomainSer-Thr/Tyr_kinase_cat_dom

EPHB3 MLKL PTK2B MERTK TEX14 CSF1R HASPIN

1.04e-031382137IPR001245
DomainUSP_1

USP11 USP9Y USP43 USP10 USP54

1.22e-03702135PS00972
DomainSAPAP

DLGAP1 DLGAP5

1.27e-0352132IPR005026
DomainGKAP

DLGAP1 DLGAP5

1.27e-0352132PF03359
DomainUCH

USP11 USP9Y USP43 USP10 USP54

1.30e-03712135PF00443
DomainUSP_2

USP11 USP9Y USP43 USP10 USP54

1.30e-03712135PS00973
DomainUSP_3

USP11 USP9Y USP43 USP10 USP54

1.39e-03722135PS50235
DomainUSP_dom

USP11 USP9Y USP43 USP10 USP54

1.39e-03722135IPR028889
DomainPeptidase_C19_UCH

USP11 USP9Y USP43 USP10 USP54

1.39e-03722135IPR001394
Pubmed

Many human endogenous retrovirus K (HERV-K) proviruses are unique to humans.

ERVK-6 ERVK-7 ERVK-10 ERVK-24

1.68e-094224410469592
Pubmed

Galectin-9 regulates follicular helper T cells to inhibit humoral autoimmunity-induced pulmonary fibrosis.

LGALS9C LGALS9B LGALS9

2.64e-073224333316546
Pubmed

Protective effect of Galectin-9 in murine model of lung emphysema: Involvement of neutrophil migration and MMP-9 production.

LGALS9C LGALS9B LGALS9

2.64e-073224328704475
Pubmed

Galectin-9 protein is up-regulated in astrocytes by tumor necrosis factor and promotes encephalitogenic T-cell apoptosis.

LGALS9C LGALS9B LGALS9

2.64e-073224323836896
Pubmed

Sequence and mapping of galectin-5, a beta-galactoside-binding lectin, found in rat erythrocytes.

LGALS9C LGALS9B LGALS9

2.64e-07322437890611
Pubmed

Galectin-9 Is a Novel Regulator of Epithelial Restitution.

LGALS9C LGALS9B LGALS9

2.64e-073224332380082
Pubmed

Galectin-9-mediated protection from allo-specific T cells as a mechanism of immune privilege of corneal allografts.

LGALS9C LGALS9B LGALS9

2.64e-073224323667648
Pubmed

Regulatory T Cell-Mediated Suppression of Inflammation Induced by DR3 Signaling Is Dependent on Galectin-9.

LGALS9C LGALS9B LGALS9

2.64e-073224328877989
Pubmed

Galectin-9 ameliorates immune complex-induced arthritis by regulating Fc gamma R expression on macrophages.

LGALS9C LGALS9B LGALS9

2.64e-073224319800850
Pubmed

Oncogenic miR-93-5p/Gal-9 axis drives CD8 (+) T-cell inactivation and is a therapeutic target for hepatocellular carcinoma immunotherapy.

LGALS9C LGALS9B LGALS9

2.64e-073224337105392
Pubmed

Galectin-9/Tim-3 pathway mediates dopaminergic neurodegeneration in MPTP-induced mouse model of Parkinson's disease.

LGALS9C LGALS9B LGALS9

2.64e-073224336479526
Pubmed

Profiling Lgals9 splice variant expression at the fetal-maternal interface: implications in normal and pathological human pregnancy.

LGALS9C LGALS9B LGALS9

2.64e-073224323242525
Pubmed

Galectin-9 in allergic airway inflammation and hyper-responsiveness in mice.

LGALS9C LGALS9B LGALS9

2.64e-073224319851072
Pubmed

The Role of Galectin-9 as Mediator of Atopic Dermatitis: Effect on Keratinocytes.

LGALS9C LGALS9B LGALS9

2.64e-073224333923930
Pubmed

Intracellular Galectin-9 Enhances Proximal TCR Signaling and Potentiates Autoimmune Diseases.

LGALS9C LGALS9B LGALS9

2.64e-073224331969388
Pubmed

Galectin-9 functionally impairs natural killer cells in humans and mice.

LGALS9C LGALS9B LGALS9

2.64e-073224323408620
Pubmed

Galectin-9 Is Critical for Mucosal Adaptive Immunity through the T Helper 17-IgA Axis.

LGALS9C LGALS9B LGALS9

2.64e-073224329458010
Pubmed

Cooperative Interactions of Oligosaccharide and Peptide Moieties of a Glycopeptide Derived from IgE with Galectin-9.

LGALS9C LGALS9B LGALS9

2.64e-073224326582205
Pubmed

Developmental regulation, expression, and apoptotic potential of galectin-9, a beta-galactoside binding lectin.

LGALS9C LGALS9B LGALS9

2.64e-07322439153289
Pubmed

Cell surface galectin-9 expressing Th cells regulate Th17 and Foxp3+ Treg development by galectin-9 secretion.

LGALS9C LGALS9B LGALS9

2.64e-073224323144904
Pubmed

The N- and C-terminal carbohydrate recognition domains of galectin-9 contribute differently to its multiple functions in innate immunity and adaptive immunity.

LGALS9C LGALS9B LGALS9

2.64e-073224321146220
Pubmed

Crystal structure of the galectin-9 N-terminal carbohydrate recognition domain from Mus musculus reveals the basic mechanism of carbohydrate recognition.

LGALS9C LGALS9B LGALS9

2.64e-073224316990264
Pubmed

Structural analysis of the human galectin-9 N-terminal carbohydrate recognition domain reveals unexpected properties that differ from the mouse orthologue.

LGALS9C LGALS9B LGALS9

2.64e-073224318005988
Pubmed

Galectin-9 ameliorates clinical severity of MRL/lpr lupus-prone mice by inducing plasma cell apoptosis independently of Tim-3.

LGALS9C LGALS9B LGALS9

2.64e-073224323585851
Pubmed

Alarmin function of galectin-9 in murine respiratory tularemia.

LGALS9C LGALS9B LGALS9

2.64e-073224325898318
Pubmed

Galectin-9 suppresses the generation of Th17, promotes the induction of regulatory T cells, and regulates experimental autoimmune arthritis.

LGALS9C LGALS9B LGALS9

2.64e-073224318282810
Pubmed

The protective function of galectin-9 in liver ischemia and reperfusion injury in mice.

LGALS9C LGALS9B LGALS9

2.64e-073224325931247
Pubmed

Galectin-9 protects mice from the Shwartzman reaction by attracting prostaglandin E2-producing polymorphonuclear leukocytes.

LGALS9C LGALS9B LGALS9

2.64e-073224317560833
Pubmed

Galectin-9 is a high affinity IgE-binding lectin with anti-allergic effect by blocking IgE-antigen complex formation.

LGALS9C LGALS9B LGALS9

2.64e-073224319776007
Pubmed

Identification and characterization of galectin-9, a novel beta-galactoside-binding mammalian lectin.

LGALS9C LGALS9B LGALS9

2.64e-07322439038233
Pubmed

Galectin-9 suppresses Th17 cell development in an IL-2-dependent but Tim-3-independent manner.

LGALS9C LGALS9B LGALS9

2.64e-073224322341088
Pubmed

The effect of Toxoplasma gondii infection on galectin-9 expression in decidual macrophages contributing to dysfunction of decidual NK cells during pregnancy.

LGALS9C LGALS9B LGALS9

2.64e-073224338987795
Pubmed

Obesity-induced galectin-9 is a therapeutic target in B-cell acute lymphoblastic leukemia.

LGALS9C LGALS9B LGALS9

2.64e-073224335241678
Pubmed

Possible regulatory role of galectin-9 on Ascaris suum-induced eosinophilic lung inflammation in mice.

LGALS9C LGALS9B LGALS9

2.64e-073224322627368
Pubmed

Galectin-9 is required for endometrial regenerative cells to induce long-term cardiac allograft survival in mice.

LGALS9C LGALS9B LGALS9

2.64e-073224333153471
Pubmed

T cell immunoglobulin and mucin protein-3 (Tim-3)/Galectin-9 interaction regulates influenza A virus-specific humoral and CD8 T-cell responses.

LGALS9C LGALS9B LGALS9

2.64e-073224322052881
Pubmed

Galectin-9 supports primary T cell transendothelial migration in a glycan and integrin dependent manner.

LGALS9C LGALS9B LGALS9

2.64e-073224335643073
Pubmed

Galectin-9 expands unique macrophages exhibiting plasmacytoid dendritic cell-like phenotypes that activate NK cells in tumor-bearing mice.

LGALS9C LGALS9B LGALS9

2.64e-073224318974023
Pubmed

Impaired Gal-9 Dysregulates the PBMC-Induced Th1/Th2 Imbalance in Abortion-Prone Matings.

LGALS9C LGALS9B LGALS9

2.64e-073224329651447
Pubmed

Regulation of M1‑type and M2‑type macrophage polarization in RAW264.7 cells by Galectin‑9.

LGALS9C LGALS9B LGALS9

2.64e-073224328990062
Pubmed

Galectin-9 suppresses tumor metastasis by blocking adhesion to endothelium and extracellular matrices.

LGALS9C LGALS9B LGALS9

2.64e-073224318579572
Pubmed

Galectin-9 ameliorates anti-GBM glomerulonephritis by inhibiting Th1 and Th17 immune responses in mice.

LGALS9C LGALS9B LGALS9

2.64e-073224324477688
Pubmed

A unique role for galectin-9 in angiogenesis and inflammatory arthritis.

LGALS9C LGALS9B LGALS9

2.64e-073224329433546
Pubmed

Amelioration of bleomycin-induced pulmonary fibrosis via TGF-β-induced Smad and non-Smad signaling pathways in galectin-9-deficient mice and fibroblast cells.

LGALS9C LGALS9B LGALS9

2.64e-073224331937306
Pubmed

Intestinal epithelial cells express galectin-9 in patients with food allergy that plays a critical role in sustaining allergic status in mouse intestine.

LGALS9C LGALS9B LGALS9

2.64e-073224321426359
Pubmed

Galectin-9 is a suppressor of T and B cells and predicts the immune modulatory potential of mesenchymal stromal cell preparations.

LGALS9C LGALS9B LGALS9

2.64e-073224324083426
Pubmed

Galectin-9 in synergy with NF-κB inhibition restores immune regulatory capability in dendritic cells of subjects with food allergy.

LGALS9C LGALS9B LGALS9

2.64e-073224337279535
Pubmed

Genomewide screening for fusogenic human endogenous retrovirus envelopes identifies syncytin 2, a gene conserved on primate evolution.

ERVK-6 ERVK-9 ERVK-19 ERVK-8

7.96e-0712224414557543
Pubmed

Contrasting acute graft-versus-host disease effects of Tim-3/galectin-9 pathway blockade dependent upon the presence of donor regulatory T cells.

LGALS9C LGALS9B LGALS9

1.05e-064224322677125
Pubmed

Role of Tim-3/galectin-9 inhibitory interaction in viral-induced immunopathology: shifting the balance toward regulators.

LGALS9C LGALS9B LGALS9

1.05e-064224319234217
Pubmed

Tim-3/Galectin-9 signaling pathway is involved in the cytokine changes in mice with alveolar echinococcosis.

LGALS9C LGALS9B LGALS9

1.05e-064224335715604
Pubmed

Galectin-9 increases Tim-3+ dendritic cells and CD8+ T cells and enhances antitumor immunity via galectin-9-Tim-3 interactions.

LGALS9C LGALS9B LGALS9

1.05e-064224319017954
Pubmed

Galectin-9: A novel promoter of atherosclerosis progression.

LGALS9C LGALS9B LGALS9

1.05e-064224336459823
Pubmed

Galectin-9 inhibits TLR7-mediated autoimmunity in murine lupus models.

LGALS9C LGALS9B LGALS9

1.05e-064224329611821
Pubmed

Lgals9 deficiency ameliorates obesity by modulating redox state of PRDX2.

LGALS9C LGALS9B LGALS9

1.05e-064224333727589
Pubmed

[Expression and significance of galectin-3 and galectin-9 in mice nasal mucosa with allergic rhinitis].

LGALS9C LGALS9B LGALS9

1.05e-064224318826117
Pubmed

[Expression of Galectin-9 and Tim-3 in lungs of mice with asthma].

LGALS9C LGALS9B LGALS9

1.05e-064224321575348
Pubmed

Activation of Tim-3-Galectin-9 pathway improves survival of fully allogeneic skin grafts.

LGALS9C LGALS9B LGALS9

1.05e-064224318346632
Pubmed

Attenuation of Th1 response through galectin-9 and T-cell Ig mucin 3 interaction inhibits autoimmune diabetes in NOD mice.

LGALS9C LGALS9B LGALS9

1.05e-064224319670381
Pubmed

Recipient T cell TIM-3 and hepatocyte galectin-9 signalling protects mouse liver transplants against ischemia-reperfusion injury.

LGALS9C LGALS9B LGALS9

1.05e-064224325450716
Pubmed

Galectin-9 regulates the threshold of B cell activation and autoimmunity.

LGALS9C LGALS9B LGALS9

1.05e-064224334369876
Pubmed

Targeting the CD146/Galectin-9 axis protects the integrity of the blood-brain barrier in experimental cerebral malaria.

LGALS9C LGALS9B LGALS9

1.05e-064224333203936
Pubmed

Galectin-9 Targets NLRP3 for Autophagic Degradation to Limit Inflammation.

LGALS9C LGALS9B LGALS9

1.05e-064224333963043
Pubmed

Lipopolysaccharide mediates time-dependent macrophage M1/M2 polarization through the Tim-3/Galectin-9 signalling pathway.

LGALS9C LGALS9B LGALS9

1.05e-064224330763585
Pubmed

Tim-3-Galectin-9 pathway involves the suppression induced by CD4+CD25+ regulatory T cells.

LGALS9C LGALS9B LGALS9

1.05e-064224319362679
Pubmed

Galectin-9/TIM-3 interaction regulates virus-specific primary and memory CD8 T cell response.

LGALS9C LGALS9B LGALS9

1.05e-064224320463811
Pubmed

Galectin-9 controls the therapeutic activity of 4-1BB-targeting antibodies.

LGALS9C LGALS9B LGALS9

1.05e-064224324958847
Pubmed

Galectin-9 binds IgM-BCR to regulate B cell signaling.

LGALS9C LGALS9B LGALS9

1.05e-064224330120235
Pubmed

Influence of galectin-9/Tim-3 interaction on herpes simplex virus-1 latency.

LGALS9C LGALS9B LGALS9

1.05e-064224322021615
Pubmed

SARS-Cov-2 spike induces intestinal barrier dysfunction through the interaction between CEACAM5 and Galectin-9.

LGALS9C LGALS9B LGALS9

1.05e-064224338686388
Pubmed

The Galectin-9/Tim-3 pathway is involved in the regulation of NK cell function at the maternal-fetal interface in early pregnancy.

LGALS9C LGALS9B LGALS9

1.05e-064224325578313
Pubmed

The expression of Galectin-9 correlates with mTOR and AMPK in murine colony-forming erythroid progenitors.

LGALS9C LGALS9B LGALS9

1.05e-064224338853593
Pubmed

The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity.

LGALS9C LGALS9B LGALS9

1.05e-064224316286920
Pubmed

Newly characterized decidual Tim-3+ Treg cells are abundant during early pregnancy and driven by IL-27 coordinately with Gal-9 from trophoblasts.

LGALS9C LGALS9B LGALS9

1.05e-064224333107565
Pubmed

Intestinal Lamina Propria CD4+ T Cells Promote Bactericidal Activity of Macrophages via Galectin-9 and Tim-3 Interaction during Salmonella enterica Serovar Typhimurium Infection.

LGALS9C LGALS9B LGALS9

1.05e-064224329844236
Pubmed

Lumenal Galectin-9-Lamp2 interaction regulates lysosome and autophagy to prevent pathogenesis in the intestine and pancreas.

LGALS9C LGALS9B LGALS9

1.05e-064224332855403
Pubmed

Galectin-3 mediates oligomerization of secreted hensin using its carbohydrate-recognition domain.

LGALS9C LGALS9B LGALS9

1.05e-064224323657851
Pubmed

The Tim-3/galectin-9 pathway involves in the homeostasis of hepatic Tregs in a mouse model of concanavalin A-induced hepatitis.

LGALS9C LGALS9B LGALS9

1.05e-064224324333756
Pubmed

Human endogenous retrovirus K10: expression of Gag protein and detection of antibodies in patients with seminomas.

ERVK-6 ERVK-10 ERVK-19

1.05e-06422437983737
Pubmed

Isolation and characterization of a novel eosinophil-specific galectin released into the lungs in response to allergen challenge.

LGALS9C LGALS9B LGALS9

1.05e-064224311839756
Pubmed

Human variation in alcohol response is influenced by variation in neuronal signaling genes.

IMPG1 PDSS1 ITGA2 PDE10A BDKRB2 RYR3 DICER1 ENTPD4 EGF

1.83e-06171224920201926
Pubmed

A phenotype survey of 36 mutant mouse strains with gene-targeted defects in glycosyltransferases or glycan-binding proteins.

LGALS9C LGALS9B MGAT3 MGAT5B LGALS9

2.17e-0633224523118208
Pubmed

Galectin-9 mediates neutrophil capture and adhesion in a CD44 and β2 integrin-dependent manner.

LGALS9C LGALS9B LGALS9

2.61e-065224334847625
Pubmed

Astrocyte galectin-9 potentiates microglial TNF secretion.

LGALS9C LGALS9B LGALS9

2.61e-065224325158758
Pubmed

Feto-maternal immune regulation by TIM-3/galectin-9 pathway and PD-1 molecule in mice at day 14.5 of pregnancy.

LGALS9C LGALS9B LGALS9

2.61e-065224326278059
Pubmed

Embryonic implantation in galectin 1/galectin 3 double mutant mice.

LGALS9C LGALS9B LGALS9

2.61e-06522439566950
Pubmed

Deficiency in Galectin-3, -8, and -9 impairs immunity to chronic Mycobacterium tuberculosis infection but not acute infection with multiple intracellular pathogens.

LGALS9C LGALS9B LGALS9

2.61e-065224337352334
Pubmed

Serial transplantation unmasks galectin-9 contribution to tumor immune escape in the MB49 murine model.

LGALS9C LGALS9B LGALS9

2.61e-065224333664349
Pubmed

Tim-3 signaling in peripheral NK cells promotes maternal-fetal immune tolerance and alleviates pregnancy loss.

LGALS9C LGALS9B LGALS9

2.61e-065224328951537
Pubmed

Quantitation of HERV-K env gene expression and splicing in human breast cancer.

ERVK-6 ERVK-7 ERVK-19

2.61e-065224312629516
Pubmed

Coexpression of Tim-3 and PD-1 identifies a CD8+ T-cell exhaustion phenotype in mice with disseminated acute myelogenous leukemia.

LGALS9C LGALS9B LGALS9

2.61e-065224321385853
Pubmed

Crystal structure of murine 4-1BB and its interaction with 4-1BBL support a role for galectin-9 in 4-1BB signaling.

LGALS9C LGALS9B LGALS9

2.61e-065224329242193
Pubmed

Tim-2 up-regulation and galectin-9-Tim-3 pathway activation in Th2-biased response in Schistosoma japonicum infection in mice.

LGALS9C LGALS9B LGALS9

2.61e-065224322469568
Pubmed

C/EBPzeta (CHOP/Gadd153) is a negative regulator of LPS-induced IL-6 expression in B cells.

LGALS9C LGALS9B LGALS9

2.61e-065224319782405
Pubmed

The glucose transporter 2 regulates CD8+ T cell function via environment sensing.

LGALS9C LGALS9B LGALS9

2.61e-065224337884694
Pubmed

A revised nomenclature for transcribed human endogenous retroviral loci.

ERVK-6 ERVK-7 ERVK-9 ERVK-10 ERVK-19 ERVK-24 ERVK-8

2.66e-0694224721542922
Pubmed

Secreted IgD Amplifies Humoral T Helper 2 Cell Responses by Binding Basophils via Galectin-9 and CD44.

LGALS9C LGALS9B CDH23 LGALS9

2.87e-0616224430291028
Pubmed

The testis-specific VAD1.3/AEP1 interacts with β-actin and syntaxin 1 and directs peri-nuclear/Golgi expression with bipartite nucleus localization (BNL) sequence.

SPATA31A7 SPATA31A3 SPATA31A5

5.20e-066224320850414
Pubmed

Tim3 binding to galectin-9 stimulates antimicrobial immunity.

LGALS9C LGALS9B LGALS9

5.20e-066224320937702
Pubmed

Human endogenous retrovirus HERV-K(HML-2) proviruses with Rec protein coding capacity and transcriptional activity.

ERVK-6 ERVK-9 ERVK-19

5.20e-066224315063128
Cytoband3q13.3

DRD3 GSK3B

1.43e-04422523q13.3
GeneFamilyCadherin related

DCHS2 CLSTN3 CDH23 CDHR4

8.95e-0617146424
GeneFamilyCD molecules|MRH domain containing

ERLEC1 IGF2R PRKCSH

1.01e-05614631233
GeneFamilyUbiquitin specific peptidases

USP11 USP9Y USP43 USP10 USP54

8.79e-05561465366
GeneFamilyGalectins

LGALS9C LGALS9B LGALS9

2.19e-04151463629
GeneFamilyBlood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing

HMCN2 MERTK VSIG10 HMCN1 LRIG1 ROBO1 MYOM2

3.36e-041611467593
GeneFamilyImmunoglobulin like domain containing

PECAM1 CD84 HMCN2 MERTK VSIG10 CSF1R MYOM2

9.86e-041931467594
GeneFamilyHyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing

CSMD3 SVEP1 PAPPA SEZ6L

1.16e-035714641179
GeneFamilySchlafen family

SLFN11 SLFNL1

1.32e-03714621110
GeneFamilyFibulins

HMCN2 HMCN1

1.76e-0381462556
GeneFamilyMannosyl-glycoprotein N-acetylglucosaminyltransferases

MGAT3 MGAT5B

2.25e-0391462435
ToppCellfacs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CSMD3 RYR3 CACNA1F ZAN ARFGEF3 LOXHD1 HMCN1 ROBO1 ZNF488 MYOM2 SPAG17

2.05e-09184219112cbed6462fea2622871bb7e49b0df3d984239281
ToppCellfacs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CSMD3 RYR3 CACNA1F ZAN ARFGEF3 LOXHD1 HMCN1 ROBO1 ZNF488 MYOM2 SPAG17

2.05e-09184219112b19a8c5f823e00812908b23e66bb4e563278aff
ToppCellfacs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CSMD3 RYR3 CACNA1F ZAN ARFGEF3 LOXHD1 HMCN1 ROBO1 ZNF488 MYOM2 SPAG17

2.05e-0918421911ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCellTracheal-NucSeq-Immune_Myeloid-Macrophage_other-Macro_CHIT1|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

INPP5D PECAM1 TPBGL CD84 MERTK ALOX15B MPEG1 GPRIN3 CPM ARRB2 CSF1R

4.65e-09199219116ce7612ee2ae211eb0f73391e96089ad5431c537
ToppCell343B-Myeloid-Dendritic-cDC_proliferating_2|Myeloid / Donor, Lineage, Cell class and subclass (all cells)

RHOJ RCC1 CHEK1 BUB1B POLE2 PFN4 HMCN1 PAXIP1 CLSPN MYBL1

1.10e-08167219103461d14e36f09ddc6ee5549ca4797e16d3f37fcc
ToppCellInfluenza_Severe-Plasmablast|World / Disease group and Cell class

DLGAP5 KIF4A BUB1B CCDC163 POLE2 KIAA1549 ARFGEF3 IGHA1 IGHA2 HASPIN

1.73e-081752191014df8fc6f6beae1be7b7bd5837546d1ac1239a6f
ToppCelldroplet-Kidney-nan-21m-Myeloid-nan|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

DLGAP1 TPBGL FBXO17 MLKL BUB1B CACNA1F CH25H ARRB2 CSF1R

1.74e-071702199510625bd725d3590cffcd7acd1d42219f6eb1139
ToppCell343B-Lymphocytic-CD4_T-cell-Proliferating_T_cell|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)

DLGAP5 KIF4A RYR3 BUB1B CRHBP TG DDIAS STON2 CLSPN

1.83e-0717121994ccd88cf812dd8bfdc55159c6f504e9c84e4f4fc
ToppCellPCW_13-14-Endothelial-Endothelial_mature-endo_arterial_(9)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung

CNTNAP3B INPP5D PECAM1 CNTNAP3 ITGA2 THSD1 EXOC6 GPRIN3 LGALS9

2.57e-071782199c227da59dc7beb73f84405bf13356bdeb59d9338
ToppCellPCW_10-12-Endothelial-Endothelial_mature-endo_arterial_(9)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung

CNTNAP3B INPP5D PECAM1 CNTNAP3 ITGA2 THSD1 EXOC6 GPRIN3 LGALS9

3.40e-071842199a809b0fa52df8a159f60f87eefcef61220af5e34
ToppCellControl-Epithelial-Basal|Epithelial / Disease state, Lineage and Cell class

ITGA2 KCNQ5 NHS FERMT1 CH25H RGS12 TG STON2 ROBO1

3.56e-071852199d5d6d13e2f20b54ca55645b9a757b8599f4fd897
ToppCellAdult-Mesenchymal-matrix_fibroblast_1_cell-D175|Adult / Lineage, Cell type, age group and donor

DLGAP1 RHOJ CDH23 ITGA2 SVEP1 GRIA1 HMCN1 ROBO1 PAPPA

3.90e-071872199e15d2967aac248da3517bc2c7d1beaa1d5a0aa7f
ToppCellBac-SEP-Lymphocyte-B-Plasmablast|Bac-SEP / Disease, Lineage and Cell Type

DLGAP5 KIF4A CHEK1 ERLEC1 BUB1B POLE2 IGHA1 IGHA2 CLSPN

4.26e-0718921996339b6d1056e07cefb0e1b2a0e479913c5783c8a
ToppCell3'-Child04-06-SmallIntestine-Epithelial-goblet|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

LGALS9C HK2 LGALS9B NR4A1 QSOX1 FCGBP PRUNE2 ARFGEF3 NTN4

5.31e-071942199fb935df966c451e659b8bde281f8aebcb632f6cf
ToppCell3'-Child04-06-SmallIntestine-Epithelial-goblet-Goblet_cell|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

LGALS9C HK2 LGALS9B NR4A1 QSOX1 FCGBP PRUNE2 ARFGEF3 NTN4

5.31e-07194219949cc5f5de4380302100e8cd937f08abe317ac75e
ToppCellAdult-Immune-interstitial_macrophage_(C1Q_positive)-D231|Adult / Lineage, Cell type, age group and donor

SLC36A1 INPP5D CDH23 CD84 MERTK MPEG1 ARRB2 CSF1R STON2

5.31e-071942199800d3d7a9e864d2d6a100a4e4af22f45d5790a8d
ToppCellFetal_29-31_weeks-Immune-interstitial_macrophage_(C1Q_positive)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

SLC36A1 INPP5D CD84 MERTK MPEG1 GPRIN3 ARRB2 CSF1R STON2

5.54e-071952199312d9625655b38f1a7c2bf8f8bb7b667ebdf9617
ToppCell3'-Child09-12-SmallIntestine-Epithelial-goblet|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

LGALS9C HK2 LGALS9B NR4A1 QSOX1 FCGBP PRUNE2 ARFGEF3 NTN4

5.78e-071962199c2d17630f7bfc9e727de55e093c17fddac61b61f
ToppCell3'-Child09-12-SmallIntestine-Epithelial-goblet-Goblet_cell|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

LGALS9C HK2 LGALS9B NR4A1 QSOX1 FCGBP PRUNE2 ARFGEF3 NTN4

5.78e-07196219954c30023d04e7265373647f56fc93885804938b0
ToppCellsevere_COVID-19-T/NK_proliferative|World / disease group, cell group and cell class (v2)

DLGAP5 KIF4A CHEK1 FANCA BUB1B MTHFD1L POLE2 HASPIN CLSPN

6.04e-071972199189d97a6c2ff8803db8cc05e205c9d88dac3911f
ToppCell10x_3'_v2v3-Neoplastic-Stem-like-NPC-like-NPC-like_Prolif-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

EPHB3 DLGAP5 KIF4A CHEK1 BUB1B DDIAS CLSPN SEZ6L MYBL1

6.04e-071972199196eaecef7003ed83f323c1f157c6a3594650097
ToppCellsevere_COVID-19-T/NK_proliferative|severe_COVID-19 / disease group, cell group and cell class (v2)

DLGAP5 KIF4A CHEK1 FANCA BUB1B MTHFD1L POLE2 HASPIN CLSPN

6.30e-071982199ed86b0247006befe55400c287d334d2202b470bd
ToppCellILEUM-inflamed-(3)_MNP-(3)_Resident_macrophages|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)

CD84 MERTK CH25H MPEG1 CPM CRHBP CSF1R IGHA1 CTSD

6.30e-07198219930bf78d4d657cf5140549d3dbf43d4f00482e300
ToppCellParenchymal-NucSeq-Immune_Myeloid-Macrophage_other-Macro_AW_CX3CR1|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

INPP5D KIF4A SAMD7 CD84 FCGBP BUB1B GPRIN3 CSF1R CLSPN

6.30e-071982199732a43061d75bc5e1cf23f5056b72cd10c926668
ToppCellSepsis-Bac-SEP-Lymphocyte-B-Plasmablast|Bac-SEP / Disease, condition lineage and cell class

DLGAP5 KIF4A CHEK1 ERLEC1 BUB1B POLE2 IGHA1 IGHA2 CLSPN

6.30e-071982199614055c11d1dd2f3f2b8783ec35a8f4570cad161
ToppCellFetal_brain-fetalBrain_Zhong_nature-GW08-Stem_cells|GW08 / Sample Type, Dataset, Time_group, and Cell type.

DLGAP5 RCC1 TRRAP FANCA BUB1B MGAT5B THAP9 NMNAT3 CLSPN

6.85e-072002199691b3edf7d8449556e8bf611662eb85772959f0f
ToppCellFetal_brain-organoid_Tanaka_cellReport-GW08-Stem_cells-Neuroepithelial_cell|GW08 / Sample Type, Dataset, Time_group, and Cell type.

DLGAP5 RCC1 TRRAP FANCA BUB1B MGAT5B THAP9 NMNAT3 CLSPN

6.85e-0720021994e077aa7faddcebdfc54667f8b3990704441005b
ToppCellTracheal-10x3prime_v2-Immune_Myeloid-Macrophage_other|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations

CD84 MERTK ALOX15B TMEM150B MPEG1 CPM LGALS9 ARRB2 CSF1R

6.85e-0720021993cfb28299a55fc1c150262a7333c59a48ae65ad1
ToppCellParenchyma_Control_(B.)-Immune-TX-MoAM-2|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type

SLC36A1 CD84 FCGBP MERTK CH25H MPEG1 CPM CRHBP CSF1R

6.85e-072002199670ef1e68be0d2c6ea20ab4dea1d051a3cc89799
ToppCellFetal_brain-fetalBrain_Zhong_nature-GW08-Stem_cells-Stem_cells|GW08 / Sample Type, Dataset, Time_group, and Cell type.

DLGAP5 RCC1 TRRAP FANCA BUB1B MGAT5B THAP9 NMNAT3 CLSPN

6.85e-07200219936a110aa91a791fdf1142e7869e8aa0d342402d0
ToppCellTracheal-10x3prime_v2-Immune_Myeloid-Macrophage_other-Macrophage_intravascular|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations

CD84 MERTK ALOX15B TMEM150B MPEG1 CPM LGALS9 ARRB2 CSF1R

6.85e-072002199c210b98a75ab5d899d7278bc9b577f76a0b3970c
ToppCellFetal_brain-organoid_Tanaka_cellReport-GW08-Stem_cells|GW08 / Sample Type, Dataset, Time_group, and Cell type.

DLGAP5 RCC1 TRRAP FANCA BUB1B MGAT5B THAP9 NMNAT3 CLSPN

6.85e-072002199d17ba4239e1fd702a3d757687110f0f2c6f91ef7
ToppCellGlobus_pallidus-Neuronal-Inhibitory-iN2(Gad1Gad2)|Globus_pallidus / BrainAtlas - Mouse McCarroll V32

SAMD7 AGTR2 TRPV3 PCDHA7 C4orf54 OCSTAMP

7.36e-076421960f13fbeda23ab9df3488cfae98cb6cd7a3c1b332
ToppCellPND03-Immune-Immune_Myeloid-Monocytic-Macrophage-IM-IM_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

INPP5D TPBGL CHEK1 CACNA1F CH25H ARRB2 CSF1R CLSPN

1.25e-061592198c0e55f25271f788c08fa4b95186501fc27b2ec39
ToppCellSubstantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Gad2-Fos_(IEG_state,_GABAergic)-|Substantia_nigra / BrainAtlas - Mouse McCarroll V32

HMCN2 TRPV3 DRD3 PIWIL4 TFAP2A SLC5A2

1.26e-06702196e1ac00f4a519b6ada89f591e549874bd3eed0ca1
ToppCellSubstantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Gad2-Fos_(IEG_state,_GABAergic)--|Substantia_nigra / BrainAtlas - Mouse McCarroll V32

HMCN2 TRPV3 DRD3 PIWIL4 TFAP2A SLC5A2

1.26e-0670219627e12c0f43a996bcbed285c5ee668bef5a786d80
ToppCellSubstantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Gad2-Fos_(IEG_state,_GABAergic)|Substantia_nigra / BrainAtlas - Mouse McCarroll V32

HMCN2 TRPV3 DRD3 PIWIL4 TFAP2A SLC5A2

1.26e-06702196b6815131e87e81c10e65bc398a84dab5a74b32ac
ToppCellfacs-Lung-EPCAM-18m-Hematologic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CD84 TMEM150B CACNA1F FERMT1 CSF1R LGR6 ADAT2 MSLN

1.31e-061602198317ef81460c1a31b51119a6309b11be6a8d4ea3e
ToppCellfacs-Lung-EPCAM-18m-Hematologic-leukocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CD84 TMEM150B CACNA1F FERMT1 CSF1R LGR6 ADAT2 MSLN

1.31e-061602198e6191240c93da34fc4431a35ef496edf323cb41e
ToppCellfacs-Lung-EPCAM-18m-Hematologic-Proliferating_Immune|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CD84 TMEM150B CACNA1F FERMT1 CSF1R LGR6 ADAT2 MSLN

1.31e-0616021987217730ae14840b935b3bf9aa49becbcbcd8a682
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

DLGAP5 KIF4A FANCA BUB1B DDIAS KIF4B CLSPN MYBL1

1.51e-0616321983f434015c0cbefb31eeda133c34f75384c5f7e22
ToppCellPosterior_cortex-Hematopoietic-MICROGLIA-MI2(C1qb)-Tmem119|Posterior_cortex / BrainAtlas - Mouse McCarroll V32

INPP5D DENND1C CD84 CACNA1F MPEG1 CSF1R CTSD ADAT2

1.73e-061662198063d68f2ffb40770cb4601fa1cb6426ae26f7a37
ToppCellAdult-Immune-interstitial_macrophage_(C1Q_positive)-D122|Adult / Lineage, Cell type, age group and donor

SLC36A1 INPP5D CD84 MERTK MPEG1 CPM CSF1R STON2

1.73e-061662198be284e2e596390f05305c7bcfc316f87b963fc0b
ToppCellPosterior_cortex-Hematopoietic-MICROGLIA-MI2(C1qb)-Tmem119-MICROGLIA_Microglia.C1qb.Tmem119-Junb_(Microglia)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32

INPP5D DENND1C CD84 CACNA1F MPEG1 CSF1R CTSD ADAT2

1.73e-061662198f28d07715e6b00ca2a0df39273c5f569744be5a8
ToppCellPosterior_cortex-Hematopoietic-MICROGLIA-MI2(C1qb)-Tmem119-MICROGLIA_Microglia.C1qb.Tmem119-Junb_(Microglia)-|Posterior_cortex / BrainAtlas - Mouse McCarroll V32

INPP5D DENND1C CD84 CACNA1F MPEG1 CSF1R CTSD ADAT2

1.73e-061662198417cfb207da08fa1a0fd5f2a13c8786628667a8e
ToppCell343B-Lymphocytic-CD4_T-cell-Proliferating_T_cell|343B / Donor, Lineage, Cell class and subclass (all cells)

DLGAP5 KIF4A RYR3 BUB1B CRHBP TG DDIAS CLSPN

1.81e-061672198315cde87eed2b42a1b9b068fae94caa10ec64c70
ToppCellGlobus_pallidus-Endothelial-ENDOTHELIAL_STALK-Flt1_1-Endothelial_Stalk.Flt1.Car4_(Car4)|Globus_pallidus / BrainAtlas - Mouse McCarroll V32

CYP2E1 USP9Y RTP3 TG HMCN1 SLFNL1

1.89e-0675219670c346f92a9ac7e33fc1b9dee1dca0bf9ae0a38c
ToppCellGlobus_pallidus-Endothelial-ENDOTHELIAL_STALK-Flt1_1-Endothelial_Stalk.Flt1.Car4_(Car4)--|Globus_pallidus / BrainAtlas - Mouse McCarroll V32

CYP2E1 USP9Y RTP3 TG HMCN1 SLFNL1

1.89e-067521963167beedef7304697e9577270cdeacfc9743cee1
ToppCellGlobus_pallidus-Endothelial-ENDOTHELIAL_STALK-Flt1_1-Endothelial_Stalk.Flt1.Car4_(Car4)-|Globus_pallidus / BrainAtlas - Mouse McCarroll V32

CYP2E1 USP9Y RTP3 TG HMCN1 SLFNL1

1.89e-0675219626d6e54ed0a6c3ff57f6269c460177bc7b8bf979
ToppCellLPS-IL1RA+antiTNF-Endothelial-Endothelial-FOXM1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

DLGAP5 KIF4A FANCA BUB1B DDIAS HASPIN CLSPN MYBL1

1.98e-061692198e0607af8ae8609d43e26ff2a2cab92650bfcd5b7
ToppCellrenal_cortex_nuclei-Adult_normal_reference-Immune-Myeloid-Macrophage_Dendritic-Cycling_Mononuclear_Phagocyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

INPP5D DLGAP5 KIF4A FANCA BUB1B ALOX15B HASPIN CLSPN

1.98e-06169219854b13ab02b4c187f4754045ecfcf409749e7ccc0
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell_cycling-Cycling_Distal_Convoluted_Tubule_Cell_S-high|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

KIF4A CHEK1 FANCA BUB1B POLE2 DDIAS CLSPN MYBL1

1.98e-061692198e7514956b2e4298222ec443f98b2f5289451786e
ToppCell390C-Lymphocytic-NK_cells-Proliferating_NK_cell|390C / Donor, Lineage, Cell class and subclass (all cells)

DLGAP5 KIF4A CHEK1 HMCN2 KCNQ5 BUB1B PAXIP1 CLSPN

2.07e-0617021985319f73cff64f2bb67472c7156ee1d0f006c6fc0
ToppCellwk_15-18-Epithelial-Distal_epithelial-type_I_pneumocyte|wk_15-18 / Celltypes from embryonic and fetal-stage human lung

MGAT3 SYDE2 ALOX15B USP43 LAMA5 CPM TEX14 MSLN

2.46e-0617421982cd6638b361ca05ab83d09ce657194aed97873b7
ToppCellAdult-Epithelial-lung_goblet_cell-D231|Adult / Lineage, Cell type, age group and donor

LGALS9C DCHS2 LGALS9B LRRTM3 FCGBP NHS TFAP2A ARFGEF3

2.46e-0617421987d2f802f493f19a068e097b2909a9000e2160266
ToppCellAdult-Endothelial-endothelial_cell_of_artery-D175|Adult / Lineage, Cell type, age group and donor

CNTNAP3B RHOJ NR4A1 PDE10A PTGS2 EXOC6 THSD7A TEX14

2.56e-0617521980a65ddfa8c2e8efb5b5338cf07661cb78157a23c
ToppCellsevere_influenza-Plasmablast|World / disease group, cell group and cell class (v2)

BUB1B CCDC163 POLE2 KIAA1549 TG ARFGEF3 IGHA1 IGHA2

2.56e-061752198e6d6c44510d5dc4eb0bae820125e42366f7a4e74
ToppCellInfluenza_Severe-Plasmablast|Influenza_Severe / Disease group and Cell class

BUB1B CCDC163 POLE2 KIAA1549 ARFGEF3 IGHA1 IGHA2 HASPIN

2.56e-0617521983f9b9793d3d1b7a9b97899272b6a0d37b05c11d1
ToppCell5'-Adult-LymphNode-Endothelial-lymphatic_endothelial-LEC5_(CLDN11+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

THSD4 RHOJ PECAM1 CNTNAP3 THSD1 PTGS2 PLA1A SLC24A1

2.91e-0617821984b3ea0921bc598ebb9f63780ecdf8ad4349f3666
ToppCellAdult-Epithelial-lung_goblet_cell|Adult / Lineage, Cell type, age group and donor

LGALS9C DCHS2 LGALS9B FCGBP NHS TFAP2A ARFGEF3 LRIG1

3.03e-0617921981fc1f252ca943a2f649d1e627f56acbf15f8e058
ToppCellPCW_10-12-Endothelial-Endothelial_mature-lymphatic|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung

CNTNAP3B PECAM1 CNTNAP3 THSD1 ZP2 GPRIN3 LGALS9 STON2

3.03e-061792198ab3d08b51cd7a37582305615ee221c7a2af83b40
ToppCellPCW_10-12-Endothelial-Endothelial_mature-lymphatic-endo_lymphatic_(7)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung

CNTNAP3B PECAM1 CNTNAP3 THSD1 ZP2 GPRIN3 LGALS9 STON2

3.03e-06179219835fe9961e228ce255e3317fc244efa35b5adbf8b
ToppCellPosterior_cortex-Hematopoietic-MICROGLIA|Posterior_cortex / BrainAtlas - Mouse McCarroll V32

HK2 INPP5D DENND1C CD84 CACNA1F MPEG1 CSF1R CTSD

3.03e-0617921985122fc794509492afde4af8b1b76d51e3070ef05
ToppCellHippocampus-Macroglia-POLYDENDROCYTE-P5-P5_1-Sox4-POLYDENDROCYTE_(Neurogenesis.Sox4.Hist1h2al)|Hippocampus / BrainAtlas - Mouse McCarroll V32

DLGAP5 KIF4A FANCA DRD3 POLE2 HASPIN CLSPN

3.04e-0612621976072996987f7b05949adb86c9433e3302c4441d2
ToppCellPBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c14-MKI67-CCL5_h|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k)

DLGAP5 KIF4A FANCA BUB1B MTHFD1L POLE2 HASPIN CLSPN

3.16e-06180219842f48e646fc6e72ad3cce72409ace3a0b64020a2
ToppCellLPS-IL1RA-Endothelial-Endothelial-FOXM1|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

DLGAP5 KIF4A BUB1B POLE2 DDIAS HASPIN CLSPN MYBL1

3.16e-061802198334e2b1f6eb7d4ece20b1c7b02107863f913237f
ToppCellCOVID-19-kidney-PCT-S2|COVID-19 / Disease (COVID-19 only), tissue and cell type

CNTNAP3B DLGAP1 FBXO17 NHS PRUNE2 SLC5A2 SLC15A1 PAPPA

3.16e-061802198358923e4228035a3e90e2957392089219e90dcd7
ToppCellCOVID-19-kidney-tDL|COVID-19 / Disease (COVID-19 only), tissue and cell type

CNTNAP3B DLGAP1 FBXO17 NHS PRUNE2 SLC5A2 SLC15A1 PAPPA

3.16e-061802198864c895b5eaedefae86f5829fa344f7b686fb59f
ToppCellPosterior_cortex-Hematopoietic-MICROGLIA-MI2(C1qb)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32

INPP5D DENND1C CD84 CACNA1F MPEG1 CSF1R CTSD

3.20e-0612721970750743574c2fca8df07e11d73e8b94579209609
ToppCelldroplet-Lung-immune-endo-depleted-3m-Lymphocytic-T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

IMPG1 DLGAP5 KIF4A CHEK1 TEX14 TG DDIAS LRIG1

3.43e-0618221983948422707d6d5e021bcd7158e2eb69143613f62
ToppCellE18.5-samps-Endothelial-Mature_fetal_endothelial|E18.5-samps / Age Group, Lineage, Cell class and subclass

RHOJ INPP5D PECAM1 ITGA2 THSD1 MLKL RGS12 LGALS9

3.43e-0618221987af3b2029b7f55b923d5a4b764d4292f4ea48599
ToppCellE18.5-samps-Endothelial|E18.5-samps / Age Group, Lineage, Cell class and subclass

RHOJ INPP5D PECAM1 ITGA2 THSD1 MLKL RGS12 LGALS9

3.43e-061822198e2d799e6e7526176a6fe6515b8fbe4d83d3a3ea1
ToppCellE18.5-samps-Endothelial-Mature_fetal_endothelial-endothelial_cells_A|E18.5-samps / Age Group, Lineage, Cell class and subclass

RHOJ INPP5D PECAM1 DLGAP5 RCC1 THSD1 BUB1B LGALS9

3.43e-061822198ea4f6c8f600ffe9f8e0609637b3371a5ac48ca03
ToppCelldroplet-Lung-immune-endo-depleted-3m-Lymphocytic-Proliferating_T|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

IMPG1 DLGAP5 KIF4A CHEK1 TEX14 TG DDIAS LRIG1

3.43e-061822198fe46819c153a81911864473badc794f243705f98
ToppCellpdx-Tumor_cells-T6|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)

CNTNAP3B DLGAP1 CNTNAP3 ITGA2 NHS FERMT1 GRIA1 CPM

3.43e-0618221987b24a4f712e1ae1525e8f1c8ec4e1fc43489cbee
ToppCell3'_v3-lymph-node_spleen-Hematopoietic_Erythro-Mega-Erythrocytic_early|lymph-node_spleen / Manually curated celltypes from each tissue

DLGAP5 BUB1B POLE2 FERMT1 MALRD1 GUCY1B1 STON2 SPAG17

3.57e-0618321980d56e16d4868c752c7557acec212029eb469ed05
ToppCellStriatum-Neuronal-Inhibitory-iN2(Gad1Gad2)|Striatum / BrainAtlas - Mouse McCarroll V32

BDKRB2 HSD17B13 PCDHA7 PCDHA3 C4orf54 TLDC2

3.68e-068421969417fffe0ba79f5851920258dcd0f6c09218be13
ToppCell343B-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)

DLGAP5 KIF4A CHEK1 BDKRB2 BUB1B DDIAS CLSPN MYBL1

3.72e-0618421986b2449ac65a2322aa0479fba0d89828f243aabbe
ToppCell343B-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)

DLGAP5 KIF4A CHEK1 BDKRB2 BUB1B DDIAS CLSPN MYBL1

3.72e-061842198e90622b82fa7f16a1faaf7a4724c958f2d83341d
ToppCelldroplet-Liver-Hepatocytes-21m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

USP11 TPBGL PDE10A EXOC6 LAMA5 NTN4 NFAT5 BBS12

3.87e-061852198efcfbf5a48b3ea9a425183e5c2eec6a9585415a0
ToppCelldroplet-Liver-Hepatocytes-21m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

USP11 TPBGL PDE10A EXOC6 LAMA5 NTN4 NFAT5 BBS12

3.87e-061852198642088ace9230d38b0579853c54ff4dd8b5d5df4
ToppCellChildren_(3_yrs)-Endothelial-endothelial_cell_of_artery-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor

CNTNAP3B PECAM1 CNTNAP3 NR4A1 PDE10A EXOC6 THSD7A HMCN1

3.87e-061852198a7ae76058b2082020cadec49d63b9f4e24d21734
ToppCellURO-Lymphocyte-T_NK-T_NK_proliferative|URO / Disease, Lineage and Cell Type

DLGAP5 KIF4A CHEK1 BUB1B POLE2 HASPIN KIF4B CLSPN

3.87e-0618521980ae9c646679c69a553eda670aef0e0495feb0286
ToppCellPCW_07-8.5-Endothelial-Endothelial_mature-lymphatic|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung

CNTNAP3B INPP5D PECAM1 CNTNAP3 THSD1 ZP2 LGALS9 STON2

4.03e-0618621985d94e6dd2c92e0c46badeb1e6eb54b69af855a66
ToppCellfacs-Skin-Telogen-3m-Epithelial-actively_dividing_stem_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

DLGAP5 KIF4A FANCA BUB1B DDIAS HASPIN CLSPN MYBL1

4.03e-0618621989feef5936985e936b3d88f9d1bb012abb6468570
ToppCellPCW_07-8.5-Endothelial-Endothelial_mature-lymphatic-endo_lymphatic_(7)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung

CNTNAP3B INPP5D PECAM1 CNTNAP3 THSD1 ZP2 LGALS9 STON2

4.03e-0618621981da52e13096dfe4eb08bd0e7461cb3809b3b3deb
ToppCellfacs-Skin-Telogen-3m-Epithelial-keratinocyte_stem_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

DLGAP5 KIF4A FANCA BUB1B DDIAS HASPIN CLSPN MYBL1

4.03e-06186219889f5b06bc56674af304912d481ac697c7c870904
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

CNTNAP3B DLGAP1 NHS PRUNE2 KIAA1549 NTN4 STON2 PAPPA

4.19e-0618721989d77ca45f7563bd6f2a0c1be5d99d93ad30983f7
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Macrophage_Dendritic-Cycling_Mononuclear_Phagocyte|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

INPP5D DLGAP5 KIF4A FCGBP BUB1B DDIAS CSF1R CLSPN

4.19e-06187219873931a5ea73799095daff100b5f18853c57c74dc
ToppCellLPS-IL1RA-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

ITGA2 PLA1A SLC11A2 GK5 ARFGEF3 NTN4 SPHKAP USP54

4.36e-0618821984bdf8d49af0e9da349b16e3f012e1b0eec04cc4f
ToppCellCOVID-19-kidney-VWF+PLVAP+VCAM1+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type

CNTNAP3B RHOJ INPP5D PECAM1 PDE10A RYR3 THSD7A CRHBP

4.53e-061892198c121817ddad164e9cfe382c43d0cbc9215508d02
ToppCellrenal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

ITGA2 HECTD1 DYNC2H1 CPM TFAP2A NTN4 EGF HMCN1

4.53e-061892198e32172ad09e93f6ac6ea2b92145b2b73003f7970
ToppCellControl-Myeloid-Monocytes|Control / group, cell type (main and fine annotations)

INPP5D PECAM1 CDH23 PTK2B TG ARRB2 CSF1R SEZ6L

4.53e-0618921983335d16bd0ffa0c1ddd06d7da645299148130c3f
ToppCellEndothelial-endothelial_cell_of_artery|World / Lineage, Cell type, age group and donor

CNTNAP3B PECAM1 CNTNAP3 NR4A1 PDE10A EXOC6 THSD7A HMCN1

4.53e-061892198fdd89c71113ac99b7c800c6def8888e512ff1128
ToppCell3'-GW_trimst-2-SmallIntestine-Endothelial-lymphatic_endothelial|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

RHOJ PECAM1 CNTNAP3 THSD1 LGALS9 STON2 SLC24A1 CTSD

4.71e-06190219832400c62cb9de4c2b24af4206c21a0215ab12212
ToppCellrenal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Cycling_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

PECAM1 DLGAP5 KIF4A CHEK1 FANCA BUB1B POLE2 CLSPN

4.71e-06190219831de1727822e9818652946dfb962daee77ffad68
ToppCellPBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c12-MKI67-TYROBP|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k)

DLGAP5 KIF4A CHEK1 FANCA BUB1B POLE2 HASPIN CLSPN

4.71e-061902198c3c65d1f24e0ebdbb9adb617bed299a668f423f5
ToppCellPrimary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

THSD4 PTK2B MERTK MGAT5B THSD7A MAMLD1 TADA1 SPHKAP

4.71e-0619021981bbbf0ce222e51f9fd2daca0c18d3965fd4efd31
ToppCell(7)_Epithelial_cells-(7)_Epithelial-H_(AT1)|(7)_Epithelial_cells / Lung cell shreds - cell class (v4) and cell subclass (v4)

PLK2 INPP5D ITGA2 FERMT1 TFAP2A RGS12 STON2 LGR6

5.09e-0619221987a6dd2ae217b8f8e460d47ad128904408299458c
ToppCellRV-08._Macrophage|RV / Chamber and Cluster_Paper

INPP5D CD84 PTK2B BUB1B MERTK CPM ARRB2 CSF1R

5.29e-06193219812bf98a280f87e4d8f0c6887dfc855da72e47ac1
DiseaseDisorder of eye

CDH23 MERTK CACNA1F BBS10 SLC24A1 CTSD BBS12 TCTN2

1.29e-042122068C0015397
DiseaseEndometrioma

ITGA2 NR4A1 PTGS2 CPM MED1 DICER1 PAPPA

1.44e-041612067C0269102
DiseaseEndometriosis

ITGA2 NR4A1 PTGS2 CPM MED1 DICER1 PAPPA

1.44e-041612067C0014175
DiseasePolydactyly

DYNC2H1 TFAP2A BBS10 C2CD3 BBS12 TCTN2

1.77e-041172066C0152427
DiseaseLiver carcinoma

CYP2E1 DLGAP5 KIF4A PTGS2 RTP3 BUB1B MED1 CRHBP IGF2R EGF ROBO1 CTSD

2.53e-0450720612C2239176
DiseaseHodgkins lymphoma

FCGBP MAGEC1 ENTHD1 AOPEP RTN4RL2

2.79e-04822065EFO_0000183
Diseasedegenerative disc disease (is_marker_for)

GSK3B PAPPA

2.88e-0442062DOID:90 (is_marker_for)
Diseasecongenital stationary night blindness (is_implicated_in)

TRPV3 CACNA1F

2.88e-0442062DOID:0050534 (is_implicated_in)
Diseasehepatocellular carcinoma (is_implicated_in)

CYP2E1 PTGS2 RYR3 DICER1 IGF2R CSF1R EGF

2.94e-041812067DOID:684 (is_implicated_in)
DiseaseMajor Depressive Disorder

NR4A1 PTGS2 BDKRB2 DRD3 DEAF1 CRHBP GSK3B EGF

3.27e-042432068C1269683
Diseasesevere acute respiratory syndrome, COVID-19

THSD4 DLGAP1 INPP5D SEMA4B THSD7A MTHFD1L MAMLD1 TG NTN4 MALRD1 SLC15A1

3.30e-0444720611EFO_0000694, MONDO_0100096
DiseaseS-6-hydroxywarfarin to S-warfarin ratio measurement

DLGAP1 CSMD3 BIRC6 ASB3 STON2

3.87e-04882065EFO_0803332
DiseaseKidney Diseases

NR4A1 PTGS2 TFAP2A EGF CTSD

3.87e-04882065C0022658
DiseaseWarburton Anyane Yeboa syndrome

BUB1B BUB3

4.78e-0452062C2931286
DiseaseMosaic variegated aneuploidy syndrome 1

BUB1B BUB3

4.78e-0452062C1850343
Diseaseage-related hearing impairment

CDH23 CSMD3 DGLUCY EXOC6 MTHFD1L GRIA1 LOXHD1 ASB3 SPAG17

4.85e-043242069EFO_0005782
DiseaseUnipolar Depression

PTGS2 BDKRB2 DRD3 DEAF1 CRHBP GSK3B TG EGF

4.98e-042592068C0041696
DiseaseAutistic Disorder

PECAM1 CSMD3 TRRAP PTGS2 DRD3 GRIA1 EGF ROBO1

5.24e-042612068C0004352
Diseasephospholipase D3 measurement

SLC36A1 CTSD

7.14e-0462062EFO_0802866
DiseaseVACTERL association (implicated_via_orthology)

QSOX1 DYNC2H1

7.14e-0462062DOID:14679 (implicated_via_orthology)
Diseasepancreatic cancer (is_marker_for)

PTGS2 AGTR2 BUB1B EGF MSLN

7.27e-041012065DOID:1793 (is_marker_for)
Diseasegallbladder cancer (is_marker_for)

BUB1B EGF

9.95e-0472062DOID:3121 (is_marker_for)
DiseaseDepressive disorder

PTGS2 DRD3 DEAF1 GRIA1 CRHBP GSK3B TG ARRB2

1.02e-032892068C0011581
DiseaseCiliopathies

CDH23 DYNC2H1 BBS10 BBS12 TCTN2

1.07e-031102065C4277690
DiseaseParkinsonism (implicated_via_orthology)

PTGS2 DRD3 SLC11A2

1.07e-03292063DOID:0080855 (implicated_via_orthology)
Diseaselate-onset Alzheimers disease

THSD4 INPP5D OPLAH CPM USP10 HMCN1 LRIG1 ASB3

1.08e-032922068EFO_1001870
Diseaseautosomal recessive intellectual developmental disorder (implicated_via_orthology)

CNTNAP3B CNTNAP3

1.32e-0382062DOID:0060308 (implicated_via_orthology)
DiseaseBenign Neoplasm

BIRC6 PTGS2 CSF1R MSLN

1.33e-03682064C0086692
DiseaseNeoplasms

BIRC6 PTGS2 CSF1R MSLN

1.33e-03682064C0027651
DiseaseCarcinoma, Granular Cell

CYP2E1 PTGS2 EGF ROBO1 MSLN

1.35e-031162065C0205644
DiseaseAdenocarcinoma, Tubular

CYP2E1 PTGS2 EGF ROBO1 MSLN

1.35e-031162065C0205645
DiseaseAdenocarcinoma, Oxyphilic

CYP2E1 PTGS2 EGF ROBO1 MSLN

1.35e-031162065C0205642
DiseaseCarcinoma, Cribriform

CYP2E1 PTGS2 EGF ROBO1 MSLN

1.35e-031162065C0205643
DiseaseAdenocarcinoma, Basal Cell

CYP2E1 PTGS2 EGF ROBO1 MSLN

1.35e-031162065C0205641
DiseaseAdenocarcinoma

CYP2E1 PTGS2 EGF ROBO1 MSLN

1.35e-031162065C0001418
Diseaseeyelid sagging measurement

EPHB3 DLGAP1 KCNQ5

1.43e-03322063EFO_0009360
Diseaseurate measurement, bone density

THSD4 FANCA SEC16A MTHFD1L PARG LAMA5 THAP9 ENTPD4 TG ASB3 ROBO1 ERCC6L2-AS1

1.45e-0361920612EFO_0003923, EFO_0004531
Diseaseanorexia nervosa

ERLEC1 QSOX1 THSD7A ASB3

1.48e-03702064MONDO_0005351
Diseaseperceived unattractiveness to mosquitos measurement

INPP5D LRRC49 LAMA5 BBS12

1.64e-03722064EFO_0008380
Diseaselung cancer (implicated_via_orthology)

PTGS2 ROBO1

1.69e-0392062DOID:1324 (implicated_via_orthology)
Diseaseresponse to serotonin-norephinephrine reuptake inhibitor

BIRC6 GK5 ASB3

2.02e-03362063EFO_0006325
DiseaseMalignant Neoplasms

BIRC6 PTGS2 DICER1 CSF1R MSLN

2.09e-031282065C0006826
Diseasecystic kidney disease (implicated_via_orthology)

LAMA5 ROBO1

2.10e-03102062DOID:2975 (implicated_via_orthology)
Diseaseresponse to corticosteroid, age at assessment

THSD4 PLK2

2.10e-03102062EFO_0008007, GO_0031960
Diseaseunipolar depression, anorexia nervosa

ERLEC1 ASB3

2.10e-03102062EFO_0003761, MONDO_0005351
DiseaseMental Depression

PTGS2 DRD3 DEAF1 GRIA1 CRHBP GSK3B ARRB2

2.13e-032542067C0011570
DiseaseCognition Disorders

PTGS2 DRD3 GSK3B

2.36e-03382063C0009241
DiseaseAlcoholic Intoxication, Chronic

CYP2E1 PDE10A PTK2B DRD3 CRHBP EGF STON2

2.88e-032682067C0001973
DiseaseAllodynia

ITGA2 PTGS2 BDKRB2 DRD3

2.88e-03842064C0458247
DiseaseMechanical Allodynia

ITGA2 PTGS2 BDKRB2 DRD3

2.88e-03842064C2936719
DiseaseHyperalgesia, Secondary

ITGA2 PTGS2 BDKRB2 DRD3

2.88e-03842064C0751212
DiseaseHyperalgesia, Primary

ITGA2 PTGS2 BDKRB2 DRD3

2.88e-03842064C0751211
DiseaseHyperalgesia, Thermal

ITGA2 PTGS2 BDKRB2 DRD3

2.88e-03842064C0751214
DiseaseTactile Allodynia

ITGA2 PTGS2 BDKRB2 DRD3

2.88e-03842064C0751213
DiseaseHyperalgesia

ITGA2 PTGS2 BDKRB2 DRD3

2.88e-03842064C0020429
DiseaseMelancholia

PTGS2 GSK3B TG

2.94e-03412063C0025193
DiseaseDepression, Neurotic

PTGS2 GSK3B TG

2.94e-03412063C0282126
DiseaseNight blindness, congenital stationary, type 1

CACNA1F SLC24A1

3.06e-03122062C3501847
Diseaseliver disease (is_implicated_in)

CYP2E1 PRKCSH

3.06e-03122062DOID:409 (is_implicated_in)
DiseaseNight Blindness, Congenital Stationary, Type 1A

CACNA1F SLC24A1

3.06e-03122062C3495587
Diseasechronic kidney disease (implicated_via_orthology)

NR4A1 AGTR2

3.06e-03122062DOID:784 (implicated_via_orthology)
DiseaseNIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 2B (disorder)

CACNA1F SLC24A1

3.06e-03122062C1864877
DiseaseOligospermia

PIWIL4 DICER1

3.06e-03122062C0028960
DiseaseNIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1B

CACNA1F SLC24A1

3.06e-03122062C1850362
DiseaseC-C motif chemokine 16 measurement

ARRB2 SLFN11

3.06e-03122062EFO_0008044
DiseaseX-Linked Csnb

CACNA1F SLC24A1

3.06e-03122062C3711543
DiseaseNIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 2A

CACNA1F SLC24A1

3.06e-03122062C1848172
DiseaseAlzheimer disease, dementia

TFAP2A OCSTAMP

3.06e-03122062MONDO_0001627, MONDO_0004975
Diseasecolorectal cancer, endometrial neoplasm

MGAT5B MALRD1 AOPEP

3.15e-03422063EFO_0004230, MONDO_0005575
DiseaseDepressive Syndrome

PTGS2 GSK3B TG

3.15e-03422063C0086133
Diseaseejection fraction measurement

DLGAP1 PLK2 HMCN1

3.37e-03432063EFO_0005527
DiseaseReactive Hyperemia

PTGS2 BDKRB2

3.60e-03132062C0178824
Diseasekynurenic acid measurement

THSD7A BUB3

3.60e-03132062EFO_0010506
Diseasepleurisy (implicated_via_orthology)

PTGS2 BDKRB2

3.60e-03132062DOID:10247 (implicated_via_orthology)
DiseaseVenous Engorgement

PTGS2 BDKRB2

3.60e-03132062C0042484
DiseaseCone-rod synaptic disorder, congenital nonprogressive

CACNA1F SLC24A1

3.60e-03132062C4041558
DiseaseActive Hyperemia

PTGS2 BDKRB2

3.60e-03132062C0333233
DiseaseHyperemia

PTGS2 BDKRB2

3.60e-03132062C0020452
Diseasevisual epilepsy (biomarker_via_orthology)

PTGS2 PLD2 DRD3 GRIA1

3.69e-03902064DOID:11832 (biomarker_via_orthology)
Diseasetype 2 diabetes mellitus (biomarker_via_orthology)

CYP2E1 PTGS2 AGTR2 GSK3B ARRB2

3.79e-031472065DOID:9352 (biomarker_via_orthology)
DiseaseSchizophrenia

DLGAP1 CYP2E1 CHEK1 TRRAP PTGS2 MAGEC1 CACNA1F DRD3 GRIA1 DICER1 RGS12 GSK3B STON2 ERVK-8

3.82e-0388320614C0036341
DiseaseGastric Adenocarcinoma

TRRAP MLKL TEX14

3.83e-03452063C0278701
Diseaseneutrophil percentage of leukocytes

MSANTD5 CDH23 ERLEC1 TGFBRAP1 MERTK EXOC6 TADA1 CSF1R EGF ASB3 BBS12

3.92e-0361020611EFO_0007990
DiseaseThrombus

PTGS2 BDKRB2 MERTK

4.08e-03462063C0087086
DiseaseEndogenous depression

PTGS2 GSK3B TG

4.08e-03462063C0011573
DiseaseSaldino-Noonan Syndrome

DYNC2H1 C2CD3

4.18e-03142062C0036069
Diseaseblood urea nitrogen measurement

DLGAP1 GON4L FANCA BUB1B GPRIN3 SLC15A1 ROBO1 LGR6 NFAT5

4.69e-034522069EFO_0004741
Diseaseschizophrenia (biomarker_via_orthology)

PTGS2 GSK3B

4.80e-03152062DOID:5419 (biomarker_via_orthology)
DiseaseHSV2 virologic severity measurement

MGAT5B ZNF488

4.80e-03152062EFO_0009010
Diseasechenodeoxycholate measurement

HMCN1 ERCC6L2-AS1

4.80e-03152062EFO_0010471
Diseaseglycerate measurement

RYR3 HMCN1

4.80e-03152062EFO_0021029
Diseasenasopharynx carcinoma (is_implicated_in)

CYP2E1 CSF1R

4.80e-03152062DOID:9261 (is_implicated_in)
DiseaseRhabdomyosarcoma

BUB1B DICER1

4.80e-03152062C0035412
DiseaseThrombosis

PTGS2 BDKRB2 MERTK

4.88e-03492063C0040053
DiseaseParkinson's disease (implicated_via_orthology)

HIPK1 NR4A1 DRD3 RHOT2 GSK3B

5.00e-031572065DOID:14330 (implicated_via_orthology)
Diseasemyocardial infarction (is_implicated_in)

PECAM1 ITGA2 PTGS2 PAPPA

5.18e-03992064DOID:5844 (is_implicated_in)
Diseasehypertension (biomarker_via_orthology)

HK2 BDKRB2 PTK2B AGTR2 GSK3B ARRB2

5.36e-032272066DOID:10763 (biomarker_via_orthology)
Disease5-oxoproline measurement

SLC52A2 OPLAH

5.46e-03162062EFO_0010988
Diseaseretinal drusen

ITGA2 SVEP1 PTK2B

5.46e-03512063EFO_1001155
Diseasedepressive disorder (biomarker_via_orthology)

CYP2E1 CRHBP GSK3B

5.76e-03522063DOID:1596 (biomarker_via_orthology)

Protein segments in the cluster

PeptideGeneStartEntry
AIITGFRNVTICPNP

BUB1B

591

O60566
VNDIFCQSLPGSPFK

ERLEC1

256

Q96DZ1
PTLNGTFAQSKCPQV

BDKRB2

36

P30411
SFSCPQPQTVPVTFL

CNTNAP3

361

Q9BZ76
ASADLPNTGRPFQCI

ADAT2

141

Q7Z6V5
CELFQTSPQRGNLPT

BIRC6

3786

Q9NR09
TNGVPLFPDLQITCS

CLSTN3

661

Q9BQT9
SANIPICIFPCLSNF

CSMD3

711

Q7Z407
DKLVQGISFSQPTCP

CHEK1

336

O14757
IQAQLPPGSSVLCFT

CSRNP2

381

Q9H175
ANPCSPVQFSSTPLA

BAZ2A

1366

Q9UIF9
VSGPLAFANSCVNPF

GPR15

286

P49685
LTEQNCSILAFSQPP

FERMT1

211

Q9BQL6
CSILAFSQPPQSPEA

FERMT1

216

Q9BQL6
PFAILLGFTNSCVNP

AGTR2

301

P50052
NPNEVFCSVPGRLSL

TFAP2A

206

P05549
RTPCNAGTFSQPEKV

BUB3

126

O43684
NSFQAECVGPFSDPL

DLGAP1

51

O14490
PFTTTNTECLCINPG

POLE2

486

P56282
PNCQIRSKGFSIFPE

ADAM32

651

Q8TC27
TVGSPINNRALFPCQ

AOPEP

271

Q8N6M6
ETNFPSPFTNILCGI

DICER1

431

Q9UPY3
PGFQATPTRQACVDV

FBN3

476

Q75N90
SFRCICPPGFQVQSD

FBN3

1951

Q75N90
LCPVFVNTGFTKNPS

HSD17B13

216

Q7Z5P4
ALVCSPGQPVTFSEE

DENND1C

346

Q8IV53
ETFSVSLCPFLQVPS

BBS12

151

Q6ZW61
IGLSPFVPPQAFSQC

BBS10

346

Q8TAM1
FVPPQAFSQCEIPNT

BBS10

351

Q8TAM1
VNSFACLRQPSQGPT

MTHFD1L

446

Q6UB35
CIFLGSPPQNSTAVT

CCDC163

51

A0A0D9SF12
NCPPGFSVLQVTATD

CDH23

2081

Q9H251
LPCFINVSESQGPGT

CDHR4

21

A6H8M9
FFFTIPQNLPCSVTL

ARRB2

116

P32121
SVFSGPPCADVVNLA

MSANTD5

131

A0A3B3IT52
CQANNFSSVPLSLPP

RTN4RL2

46

Q86UN3
QLGTPGTESCFIPQN

RCC1

271

P18754
NSAVCRDFNIPGFPT

QSOX1

106

O00391
TQGQPFDPTFLIGCA

CYP2E1

161

P05181
FFSCTVGNPLVDPAI

MPEG1

531

Q2M385
QFVPPSVDTGFCNFT

KIAA1549

1051

Q9HCM3
TFLYQLPGTVQPCSS

NR4A1

66

P22736
QCGTLLPVNGFSPES

PAXIP1

81

Q6ZW49
VNGQVTCSLTPRVPF

PCDHA7

381

Q9UN72
PEGSAFFCLSQTNPL

CACNA1F

846

O60840
PLSCSGFQSTKDFPQ

ENTHD1

526

Q8IYW4
VNGQVTCSLTPHVPF

PCDHA3

381

Q9Y5H8
CTQSTFEGFPQSPLQ

MAGEC1

501

O60732
GQSIFSVPPESFVCD

LRIG1

476

Q96JA1
LQPVPVSSNGLFCAI

SLC24A1

1031

O60721
SCGVPTVVQYSNLPT

MGAT3

181

Q09327
NTAFNLTCQAVGPPE

MERTK

211

Q12866
FPSVTLISCQQPGAP

LGR6

896

Q9HBX8
TFIVCPPAFQTGLQA

HIPK1

651

Q86Z02
SAFFPTGVKVCPQES

IMPG1

71

Q17R60
PFTCLDGSATIPFDQ

PRKCSH

36

P14314
TAPFLQPVTLQCIGD

HMCN2

1821

Q8NDA2
LLTAPGPQDSAQFEC

HMCN2

3816

Q8NDA2
QPAFSTVPFSQPVCF

LGALS9C

156

Q6DKI2
LASFQIPPFECEQTS

KCNQ5

641

Q9NR82
QPAFSTVPFSQPVCF

LGALS9B

156

Q3B8N2
QPAFSTVPFSQPVCF

LGALS9

156

O00182
ILCPFTGIQQTFPCS

LOXHD1

381

Q8IVV2
LPLGFTFSFPCQQNS

HK2

596

P52789
IANGCIFLQSRFSPP

MGAT5B

546

Q3V5L5
PPVTCLDVSANQVAF

FBXW8

386

Q8N3Y1
TVNTCFLPRAGPESQ

NXF5

346

Q9H1B4
TQTVALSPLNFCGPN

OR3A4P

161

P47883
SFTVNLPFCGPNVVD

OR4K5

161

Q8NGD3
SQFLLTIFVPFCGPN

OR4P4

156

Q8NGL7
LTRQESCLGNSPPFE

PARG

281

Q86W56
FLGECNNSLCIFTPP

PDE10A

116

Q9Y233
SCSIPGAPPANFTIQ

PECAM1

346

P16284
QDFVPCSQSTPISGF

DDIAS

766

Q8IXT1
CFRFLPPAQVTVVGS

NOL6

151

Q9H6R4
PPSCLFQTEFSQGIL

OBI1

641

Q5W0B1
PQDPCQIDGSTLSAF

LRRC49

371

Q8IUZ0
NNVKGCPFTSFSVPD

PTGS2

556

P35354
FTVRDCNSIPNIPGS

EPHB3

111

P54753
FVPSCSGCRTPQIEQ

SLC11A2

241

P49281
LNPDAFSGPQACTRF

MSLN

126

Q13421
PQLQPGNCSLLSVFS

GUCY1B1

241

Q02153
PLSVPSNNFAEGCVL

LAMA5

1916

O15230
ISLGPQNVFCDVPLT

PAPPA

826

Q13219
QPPCLSVTPSQGQTF

RBM12B-AS1

66

Q9P1G2
TQGCFPQLFPVSAVT

GTPBP8

251

Q8N3Z3
FQLSASFSPATQPCP

ITGA2

156

P17301
FGICIDETVTPPQFS

MLKL

266

Q8NB16
QCELFSSPPAVSGNE

NFAT5

951

O94916
PNTDVFLICFSVVNP

RHOJ

91

Q9H4E5
QCELFASSEPVPGFQ

EXOC6

696

Q8TAG9
FSNVDVLQQTPPCSA

LRRC66

846

Q68CR7
QLTNLFCEVEGTPSP

HMCN1

1376

Q96RW7
FSSFSCIVPENLPIS

DCHS2

2771

Q6V1P9
LCVASPGFNVTPSDV

PFN4

31

Q8NHR9
NLTPVPGAPSQTCFV

FBXO17

136

Q96EF6
QSPTFSQTGPGCILS

MALRD1

721

Q5VYJ5
DPFCPFSIISNAVSN

CYP2U1

216

Q7Z449
TCPSFNTVRQGSKEP

ERVK-10

436

P87889
TCPSFNTVRQGSKEP

ERVK-19

436

Q9YNA8
ACPSFNTVRQGSKEP

ERVK-24

436

P63145
TCPSFNTVRQGSKEP

ERVK-6

436

Q7LDI9
TCPSFNTVRQGSKEP

ERVK-7

436

P63130
TCPSFNTVRQGSKEP

ERVK-8

436

P62685
TCPSFNTVRQGSKEP

ERVK-9

436

P63126
TCPSFNTVRQGSKEP

HERVK_113

436

P62684
QGAVDPSLFPSQILC

DYNC2H1

1526

Q8NCM8
PDAQACLVFGFSSPV

ASB3

306

Q9Y575
TLLCAASGYPQPNVT

CSF1R

416

P07333
QRSCGLFTAPFPQDS

HECTD1

2221

Q9ULT8
VFLKGTPEQPQCGFS

GLRX5

56

Q86SX6
PCPTLSGAQQSSTFV

C2CD3

2176

Q4AC94
FQGQLDSIPVSNPSC

CPM

396

P14384
TDPNLFPCNVISQTP

CRHBP

176

P24387
FPCNVISQTPNGKFT

CRHBP

181

P24387
PILIFPEGTCINNTS

GPAT4

316

Q86UL3
NGNSTCVGPAPFLIF

EGF

36

P01133
FQATPFCFNQSLIPG

COLCA2

21

A8K830
FCFNQSLIPGSPSNS

COLCA2

26

A8K830
FAGATVQEASVQPPC

DEAF1

371

O75398
LATGPVLFACQQFPE

PDSS1

331

Q5T2R2
PQGPFATCQAVLSPS

FCGBP

5056

Q9Y6R7
PSSVLCGSSFQAEQP

FANCA

1086

O15360
PDQTFTALQPAVFPC

ARFGEF3

2131

Q5TH69
TALQPAVFPCISQLT

ARFGEF3

2136

Q5TH69
GTPPQCFTVVFDTGS

CTSD

86

P07339
NLPFCGRSNLPDVSS

ERCC6L2-AS1

121

Q8WZB0
LPNLPCVFSSAFTQG

JMJD4

96

Q9H9V9
LSPGVAFSPCHIQQI

CELF5

266

Q8N6W0
CLVQGFFPQEPLSVT

IGHA1

26

P01876
NPTSFPCPLNQSLVA

GON4L

1186

Q3T8J9
AESCKPVQQPSAFGS

GSK3B

11

P49841
SPGLNCSNPFTQLER

DLGAP5

806

Q15398
RQPPSCQALGSESFL

MAMLD1

701

Q13495
DPSPCVVNSSISFNI

MS4A18

211

Q3C1V0
SFPTQDLTPLQNVCF

HASPIN

366

Q8TF76
VCFVPSFSGLQAPLN

GK5

371

Q6ZS86
TEVTPGLSFFNPVCA

KIF4A

1146

O95239
GLSFFNPVCATPNSK

KIF4A

1151

O95239
TPGLSFFNPVCATPN

KIF4B

1151

Q2VIQ3
NQPCPLGSVESFSLA

KLHDC8B

291

Q8IXV7
CLVQGFFPQEPLSVT

IGHA2

26

P01877
FTEPTPIQCQGFPLA

DDX17

191

Q92841
QFQVPEGLCASSPTL

PTK2B

736

Q14289
AFERFCQVNTGPLPL

DGLUCY

51

Q7Z3D6
VCFITPSFPVDTSNQ

GRIA1

106

P42261
SCEFPSPETIQGTVQ

GPRIN3

186

Q6ZVF9
AIFATQRQSFPPVCT

GYS1

431

P13807
PFTLQGAQPQVLCFS

C4orf54

1566

D6RIA3
KGFTISSTEIPPQCQ

SLC15A1

526

P46059
FSQPPVLRTASQEGC

PEX1

1171

O43933
SQSVALPPCTEPNFQ

C1orf50

181

Q9BV19
DFSPSAQQLLPCLGQ

CH25H

76

O95992
LNIENPSFTSTPICG

MYBL1

501

P10243
SFSCPQPQTVPVTFL

CNTNAP3B

361

Q96NU0
GDPTVCSISNPDFVI

DRD3

176

P35462
LQNCTGIPLFETQPT

MED1

321

Q15648
GTSQSCSLLPSQVPF

MTMR3

821

Q13615
TCEGFIATLPPVNAT

ALOX15B

586

O15296
GSTQAQAAPFPELCS

IGF2R

36

P11717
FCAGPIQVTSLPPSQ

RTP3

161

Q9BQQ7
CFGPVLLSQRQEPST

SYDE2

981

Q5VT97
QSSCLSGPNEEQPLF

UTY

596

O14607
NCPQDFLSVQPVSSA

SPHKAP

1266

Q2M3C7
QAPALCSVSFSNPEG

SEZ6L

276

Q9BYH1
PSTGQPSLCSFEINE

TEX14

616

Q8IWB6
LQGTQLASFPDTCQP

PRUNE2

2586

Q8WUY3
GCPNLTEFQVCQSSP

THSD7A

231

Q9UPZ6
GSFPPQSCIFSQVLN

TMEM150B

46

A6NC51
NNLIESPPAFTAPCA

TADA1

226

Q96BN2
PRQFCVPSQFGSSVL

SAMD7

41

Q7Z3H4
NQPRLGTDTVPVCFS

LRRC15

441

Q8TF66
PVCFSPANVRGQSLI

LRRC15

451

Q8TF66
EAFSGPSVFQCVPNL

LRRTM3

266

Q86VH5
NTPTKNCAFPTEGFQ

NHS

1261

Q6T4R5
GSAVLPANSVTFCDP

NTN4

401

Q9HB63
CAGPAEPSTTIFTQL

RHOT2

556

Q8IXI1
SFVPLQPTQDCVLTS

NEXMIF

851

Q5QGS0
ATEVNSFLTNGPCPA

OPLAH

431

O14841
FSISPVGCPRILNTN

ENTPD4

16

Q9Y227
SPAFPSLIQNTGVAC

SPATA31A7

511

Q8IWB4
NGVLPAVQSFSCLPY

SLC52A2

291

Q9HAB3
FQPNTVNTLACPLLS

SEMA4B

601

Q9NPR2
PSSSPVCIQVFNIIF

PIWIL4

196

Q7Z3Z4
PCSGSSITEIINPNY

INPP5D

901

Q92835
QVIRSNPSFNIPTGC

SLFN11

746

Q7Z7L1
IFPEGSCLNTFTKNP

CD84

256

Q9UIB8
AFSQPVPASCGQLLT

OCSTAMP

36

Q9BR26
FTPVNGDFICTPDNT

SVEP1

731

Q4LDE5
TGFSANRDPLTQVPC

STON2

711

Q8WXE9
TLDVPTFQSLNVSCP

SPAG17

1216

Q6Q759
TCPSFNTVRQGSKEP

ERVK-9

436

P63128
SPTICQTFVGRALQP

ERVK-9

1091

P63128
VGHLNPQFSVPVLAC

SLFNL1

51

Q499Z3
FELIGSTIPSYQPCN

CLSPN

776

Q9HAW4
VQFLLFVPSNPSCGQ

PLA1A

51

Q53H76
SPAFPSLIQNTGVAC

SPATA31A3

511

Q5VYP0
KVLPFNAETCNATGP

WDR47

686

O94967
TFALNENPVSGDPFC

TGFBRAP1

121

Q8WUH2
AICSPFSQDLSPVQG

ZNF595

76

Q8IYB9
PQVPDSPIFTNSLCN

USP43

761

Q70EL4
CNFNPPSNLIISGSF

WDR5B

131

Q86VZ2
QALPQNAPLCSTFLG

ZNF488

221

Q96MN9
PFNVPEGATVAFNCT

TRAV12-1

31

A0A0B4J245
SGPFCTPQSPVSLAQ

RGS12

1296

O14924
QPSNAPIFINSTCAF

SLC36A1

461

Q7Z2H8
SLGAETCPLPSFQVF

SEC16A

1791

O15027
IPEFSFGSGSCVQPS

SLC5A2

501

P31639
SPAFPSLIQNTGVAC

SPATA31A5

511

Q5VU36
LSKCQPSPGFNSNIF

THAP9

246

Q9H5L6
LFCVSPQPACNTSSF

TMPRSS7

516

Q7RTY8
TQFLSQASFIPCPVD

RYR3

841

Q15413
QVGLFTSQPLCPFPV

THSD1

146

Q9NS62
SETNVASGCPLFFPL

TRAF1

376

Q13077
RTVTFQCEATGNPQP

ROBO1

366

Q9Y6N7
IPVCSSPVTINAGFE

USP9Y

1491

O00507
NCVLSSSPNPFPEIS

ZNF8

181

P17098
FPGQVAQLSCTLSPQ

VPREB3

31

Q9UKI3
STLNPQAPEFILGCT

USP10

81

Q14694
NVTLTCQVSGAYPPA

VSIG10

326

Q8N0Z9
DFAQCTSPVPTLPQV

ZKSCAN7

196

Q9P0L1
VAAALSQPAAPCPFQ

TPBGL

16

P0DKB5
FGETPLALAACTNQP

TRPV3

261

Q8NET8
SPTICQTFVGRALQP

ERVK-19

171

Q9WJR5
GQCSVFPATDAPEQF

PLK2

551

Q9NYY3
GSSPCPTFNNEVLAR

TLDC2

186

A0PJX2
LLLGFQFVCPQPSTQ

THSD4

16

Q6ZMP0
QPAGSTLFVPACTSE

TG

676

P01266
QLPFTLPGGQCTTVQ

PLD2

591

O14939
VSQLVNPAFPGTVTC

ZP2

41

Q05996
FLLPCYQVGSQPSTA

TRRAP

1061

Q9Y4A5
PSSGVTNRCPFLLDN

USP11

686

P51784
VNPPFDQLCSAGTTT

TCTN2

211

Q96GX1
ICLPEASASFQPNLT

TMPRSS11A

291

Q6ZMR5
FLTTPGCNPQLTYTA

USP54

1556

Q70EL1
PGTQILIRSFQPCES

nan

91

Q8N9W7
PGTQILIRSFQPCES

nan

91

A6NDX4
ILAQPCGNSTDPFFR

ZAN

1181

Q9Y493
CAFPVQFRQPSVSGL

DUSP18

6

Q8NEJ0
GSVPPACFQQILSFC

NACC2

71

Q96BF6
TLNLTCTVFGNPDPE

MYOM2

1361

P54296
PVVLLACGSFNPITN

NMNAT3

6

Q96T66